Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electric and pharmacologic cardioversion

被引:33
作者
Giansante, C
Fiotti, N
Miccio, M
Altamura, N
Salvi, R
Guarnieri, G
机构
[1] Univ Trieste, Inst Clin Med, I-34149 Trieste, Italy
[2] Osped Maggiore, Emergency Unit, Trieste, Italy
关键词
D O I
10.1067/mhj.2000.108520
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to determine whether paroxysmal atrial fibrillation (PAF) and/or restoration to sinus rhythm with electric or pharmacologic cardioversion induce modifications to the coagulation system. Thirty-five patients with PAF undergoing either electric (n = 11) or pharmacologic (n = 24) cardioversion were studied. Fibrinopeptide A and D-dimer blood samples were taken immediately before and after cardioversion at different intervals. When compared with the control group (n = 70), the precardioversion fibrinopeptide A plasma values were significantly elevated (11.8 vs 2.5 ng/ml). Fibrinopeptide A plasma values were significantly reduced 5 minutes after cardioversion (11.8 vs 5.3 ng/mL) and remained stable throughout the follow-up sequential measurements. D-dimer plasma values were significantly increased (measured at 12 hours and at day 7) in patients who underwent electrical cardioversions only. A positive correlation (R-2 = 0.76) was found between the energy delivered for cardioversion to sinus rhythm and D-dimer plasma values on day 7. in patients with PAF, levels of fibrinopeptide A, an indicator of coagulation activation, are elevated and soon reduced by the restoration of sinus rhythm. Electric, but not pharmacologic, cardioversion induces an early activation of the fibrinolytic system.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 39 条
  • [1] D-Dimer testing and acute venous thromboembolism - A shortcut to accurate diagnosis?
    Becker, DM
    Philbrick, JT
    Bachhuber, TL
    Humphries, JE
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (09) : 939 - 946
  • [2] EXCLUSION OF ATRIAL THROMBUS BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY DOES NOT PRECLUDE EMBOLISM AFTER CARDIOVERSION OF ATRIAL-FIBRILLATION - A MULTICENTER STUDY
    BLACK, IW
    FATKIN, D
    SAGAR, KB
    KHANDHERIA, BK
    LEUNG, DY
    GALLOWAY, JM
    FENELEY, MP
    WALSH, WF
    GRIMM, RA
    STOLLBERGER, C
    VERHORST, PMJ
    KLEIN, AL
    [J]. CIRCULATION, 1994, 89 (06) : 2509 - 2513
  • [3] MEASUREMENT OF D-DIMER IN PLASMA AS DIAGNOSTIC-AID IN SUSPECTED PULMONARY-EMBOLISM
    BOUNAMEAUX, H
    CIRAFICI, P
    DEMOERLOOSE, P
    SCHNEIDER, PA
    SLOSMAN, D
    REBER, G
    UNGER, PF
    [J]. LANCET, 1991, 337 (8735) : 196 - 200
  • [4] DARDIK BN, 1985, BLOOD, V65, P680
  • [5] DECLERCK PJ, 1987, THROMB HAEMOSTASIS, V58, P1024
  • [6] FIBRINOPEPTIDE-A - A MARKER OF ACUTE CORONARY THROMBOSIS
    EISENBERG, PR
    SHERMAN, LA
    SCHECTMAN, K
    PEREZ, J
    SOBEL, BE
    JAFFE, AS
    [J]. CIRCULATION, 1985, 71 (05) : 912 - 918
  • [7] Use of cardiac troponin T rapid assay in the diagnosis of a myocardial injury secondary to electrical cardioversion
    Garre, L
    Alvarez, A
    Rubio, M
    Pellegrini, A
    Caridi, M
    Berardi, A
    Lazzaro, C
    Blanco, P
    Menehem, C
    Diaz, M
    [J]. CLINICAL CARDIOLOGY, 1997, 20 (07) : 619 - 621
  • [8] D-dimer and anticoagulation in patients with mechanical prosthetic heart valves - A 2-year follow-up
    Giansante, C
    Fiotti, N
    Calabrese, S
    LaVerde, R
    Pandullo, C
    Scardi, S
    Guarnieri, G
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (07) : 1320 - 1324
  • [9] GIANSANTE C, 1994, THROMB HAEMOSTASIS, V71, P581
  • [10] GOLDMAN MJ, 1960, PROG CARDIOVASC DIS, V2, P625